Anti-nuclear antibody (ANA) test is
used for detecting antinuclear antibodies in blood. The immune system can make
antibodies to fight with various infections. Sometimes, ANA in a body can
attack the tissues in that body itself. ANA tests can help doctors to determine
autoimmune ailments
The primary market driver for the
global anti-nuclear antibody (ANA) testing
market size
is increasing technological advancement. Adoption of new medical techniques and
increasing prevalence of many autoimmune diseases also drive the global
anti-nuclear antibody (ANA) testing market growth. The increasing use of
technology in medical sector is also boosting the anti-nuclear antibody (ANA)
testing market. Major brands are investing money in research & development
(R&D) to develop more advanced medical devices or equipment for the market
that can elevate the anti-nuclear antibody (ANA) testing market revenue.
Market Segmentation
The global anti-nuclear antibody (ANA)
testing market segmentation encompasses application, end-user, and type. MRFR’s
take on the market surveys various facets of the market in-depth.
The application-based segmentation of
this anti-nuclear antibody (ANA) testing
market research
report covers lupus, polymyositis, rheumatoid arthritis, scleroderma, Sjögren's
syndrome, and others. The lupus segment has been sub-segmented into discoid
lupus erythematosus, neonatal lupus, subacute cutaneous lupus erythematosus,
and systemic lupus erythematosus (SLE). The rheumatoid arthritis segment has
been sub-segmented into seropositive and seronegative. The scleroderma segment
has been sub-segmented into localized scleroderma and systemic scleroderma. The
Sjögren's syndrome has been sub-segmented into primary and secondary.
By type, the anti-nuclear antibody
(ANA) testing market has been segmented into enzyme-linked immunosorbent assay
(ELISA), immunofluorescence, and others. The ELISA segment has been
sub-segmented into competition/inhibition ELISA, direct ELISA, indirect ELISA,
and sandwich ELISA. The immunofluorescence segment has been sub-segmented into
primary (direct) and secondary (indirect).
In the context of end-user, the market
has been segmented into hospitals & clinics, research laboratories, and
others.
Regional Segmentation
A geographical outlining of the global
anti-nuclear antibody (ANA) testing market covers the Americas (North America
& South America), Europe, Asia Pacific, and the Middle East & Africa
(MEA).
The Americas is the largest regional
market as North America alone holds the potential of being the largest regional
market. Due to technological advancement and the presence of key market
players, North America is a greater market than South America. The main reason
for North America being the top regional market is the availability of advanced
medical facilities and high disposable income of patients. USA and Canada
generate the maximum revenue in the market.
Europe is the second-largest regional
market due to the availability of funds for R&D activities, availability of
advanced medical facilities, high density of population, technological
advancement, and presence of some key market players. The most powerful
country-specific markets in Western Europe are France, Germany, Italy, Spain,
and the UK.
During the forecast period, the Asia
Pacific region can be fastest growing regional market due to high density of
population, rapid development in technology, improving healthcare sector, and a
large number of people suffering from different ailments that require treatment
via ANA. The remarkable country-specific markets in this region are Australia,
China, India, Japan, and South Korea.
The MEA is the smallest regional market
due to limited development in the medical sector. Some country-specific markets
that are better than most of the markets are Egypt, Saudi Arabia, and the UAE.
Key Players
Big players in the global anti-nuclear
antibody (ANA) testing market include Abcam PLC. (USA), Alere (USA), Antibodies
Inc.(USA), Bio-Rad Laboratories, Inc. (USA), Erba Diagnostics (USA), Indur
Services, Inc. (the USA), MBL International Corporation (USA), Merck KGaA
(Germany), and Trinity Biotech (Republic of Ireland).
About
Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment